Get started
Work

338eP Immunotherapy with or without chemotherapy for first line treatment of unresectable pleural mesothelioma (PM): A systematic review and meta-analysis

Year: 2026
Type: article
Abstract: Dual immune checkpoint inhibition (ICI) represents a standard first-line treatment for PM. Moreover, strategies of platinum-based combination treatment (PCT) with ICI have also been evaluated in this setting. However, head-to-head comparisons between ICI alone and ICI+PCT are lacking.
Source: ESMO Open
DOI: 10.1016/j.esmoop.2026.106649
Authors: G. Viscardi, M. Brambilla, P. Ambrosini, A. Russo, F. Salomone, A. Nuccio, F. Vitiello, M. Gilli, A. Ponticiello, D. Rocco, R. Di Liello, C.M. Della Corte, P.M. Medusa, M. Ganzinelli, D. Signorelli, C. Proto, A. Prelaj, G. Lo Russo, R. Ferrara, M. Occhipinti
Institutions: Ospedale Monaldi, Fondazione IRCCS Istituto Nazionale dei Tumori, Federico II University Hospital, University of Naples Federico II, IRCCS Ospedale San Raffaele, University of Campania "Luigi Vanvitelli", Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Vita-Salute San Raffaele University
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7137987737
FWCI:
Cites:
Cited by:
Related to: